The sialic acid residue of exogenous GM1 ganglioside is recycled for biosynthesis of sialoglycoconjugates in rat liver
- 1 October 1987
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 247 (1) , 157-164
- https://doi.org/10.1042/bj2470157
Abstract
In order to assess metabolic recycling of sialic acid, GM1 ganglioside [nomenclature of Svennerholm (1964) J. Lipid. Res. 5, 145-155; IUPAC-IUB Recommendations (1977) Lipids 12, 455-468], 14C-radiolabelled at the acetyl group of sialic acid, was intravenously injected into Wistar rats, and the presence of radioactive sialic acid in liver sialoglycolipids (gangliosides) and sialoglycoproteins was ascertained. A time-course study (20 min-72 h) showed that the radioactivity present in the liver distributed in the following fractions, with reciprocal proportion varying with time: the protein (glycoprotein) fraction, the ganglioside fraction and the diffusible fraction, which contained low-Mr compounds, including sialic acid. Ganglioside-linked radioactivity gradually decreased with time; protein-linked radioactivity appeared soon after injection (20 min), reached a maximum around 20 h, then slowly diminished; diffusible radioactivity provided a sharp peak at 4 h, then rapidly decreased till disappearing after 40 h. The behaviour of bound radioactivity in the individual liver gangliosides was as follows: (a) rapid diminution with time in GM1, although with a lower rate at the longer times after injection; (b) early appearance (20 min) with a peak at 1 h, followed by continuous diminution, in GM2; (c) early appearance (20 min), peak at 1 h, diminution till 4 h, followed by a plateau, in GM3; (d) appearance at 60 min, maximum around 40 h and slow diminution thereafter, in GD1a, GD1b and GT1b. A detailed study, accomplished at 40 h after injection, demonstrated that almost all radioactivity present in the protein fraction was released by mild acid treatment and recovered in purified sialic acid; most of radioactive glycoprotein-bound sialic acid was releasable by sialidase action. In addition, the radioactivity present in the different gangliosides was exclusively carried by sialic acid and present in both sialidase-resistant and sialidase-labile residues. Only in the case of GD1a was the specific radioactivity of sialidase-resistant sialic acid superior to that of sialidase-releasable sialic acid. The results obtained lead to the following conclusions: (a) radioactive GM3 and GM2 were produced by degradation of GM1 taken up; GM3 originated partly by a process of neosynthesis; (b) radioactive GM1 consisted in part of residual exogenous GM1 and in part of a neosynthetized product; (c) radioactive GD1a originated in part by direct sialylation of GM1 taken up and in part by a neosynthetic process; (d) radioactive GD1b and GT1b resulted only from neosynthesis. In the process of neosynthesis, the sialic acid moiety, released during intracellular degradation of GM1 taken up, was re-utilized.This publication has 27 references indexed in Scilit:
- Ganglioside GM1 metabolism in living human fibroblasts with ?-galactosidase deficiencyHuman Genetics, 1986
- Sialic Acid Storage Disease with Sialuria: Clinical and Biochemical Features in the Severe Infantile TypePediatrics, 1983
- Infantile form of sialic acid storage disorder: Clinical, ultrastructural, and biochemical studies in two siblingsEuropean Journal of Pediatrics, 1982
- Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes.Journal of Biological Chemistry, 1982
- Studies on the Cell Association of Exogenously Added Sialo-GlycolipidsHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1982
- Turnover of Free Sialic Acid, CMP‐Sialic Acid, and Bound Sialic Acid In Rat BrainJournal of Neurochemistry, 1981
- Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N-acetylneuraminic acid.Journal of Biological Chemistry, 1980
- Metabolism of N-acetylneuraminic acid in mammals: isolation and characterization of CMP-N-acetylneuraminic acidBiochemistry, 1979
- 'Salla Disease'Archives of Neurology, 1979
- A new procedure for the extraction, purification and fractionation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973